Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Amoxicillin

Amoxicillin

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Amoxicillin:

 BioPortfolio Logo
MiddleBrook Pharmaceuticals Announces Stockholder Approval and Closing of $100 Million Financing Transaction with Equity Group Investments 4th September, 2008 MiddleBrook Pharmaceuticals, Inc.
GERMANTOWN, Md., Sept. 4 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective
MiddleBrook Pharmaceuticals Files Definitive Proxy Statement with Respect to Proposed $100 Million Investment from EGI 30th July, 2008 MiddleBrook Pharmaceuticals, Inc.
GERMANTOWN, Md., July 30 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective

This page has been viewed 21 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Amoxicillin across BioPortfolio, or for Amoxicillin Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.